Targeting ROS1 rearrangements in non-small cell lung cancer with crizotinib and other kinase inhibitors

TRANSLATIONAL CANCER RESEARCH

AME PUBL CO

1. National Institutes of Health (NIH)/National Cancer Institute (NCI) [R37CA218707]